Article Hero

Walgreens posted mixed quarterly earnings

1602773075.jpg
Miguel A. Rodriguez
Miguel A. Rodriguez
15 October 2020
Profit fell less than forecasted

One of the largest pharma chains in the US, Walgreens had its financial report. The figures came in mixed.

The quarterly profit fell less than expected to $373 million, or 43 cents per share. The last year’s figures were $677 million. The EPS decreased to $1.02, but it topped the 96 cents consensus.

Walgreens sales rose 2.3% to $34.75 billion. The market was looking for $34.37 billion.  At a US level, sales increased 3.6% to $27 billion.

At a global level, sales dropped 14.9% to $2.3 billion. However, the figures came in higher than the $2.2 billion expected.

For the future, Walgreen expects strong EPS growth.

Following the news, Walgreen stock price gained almost 3%. Year-to-date, the stock dropped 39%.

Sources: marketwatch.com

This information prepared by capex.com/za is not an offer or a solicitation for the purpose of purchase or sale of any financial products referred to herein or to enter into any legal relations, nor an advice or a recommendation with respect to such financial products.This information is prepared for general circulation. It does not regard to the specific investment objectives, financial situation, or the particular needs of any recipient.You should independently evaluate each financial product and consider the suitability of such a financial product, by taking into account your specific investment objectives, financial situation, or particular needs, and by consulting an independent financial adviser as needed, before dealing in any financial products mentioned in this document.This information may not be published, circulated, reproduced, or distributed in whole or in part to any other person without the Company’s prior written consent.
Past performance is not always indicative of likely or future performance. Any views or opinions presented are solely those of the author and do not necessarily represent those of capex.com/zaJME Financial Services (Pty) Ltd trading as CAPEX.COM/ZA acts as intermediary between the investor and Magnasale Trading Ltd, the counterparty to the contract for difference purchased by the Investor via CAPEX.COM/ZA, authorised & regulated by the Cyprus Securities and Exchange Commission with license number 264/15.  Magnasale Trading Ltd is the principal to the CFD purchased by investors.

Share this article

How did you find this article?

Awful
Ok
Great
Awesome

Read More

Miguel A. Rodriguez
Miguel A. Rodriguez
Financial Writer

Miguel worked for major financial institutions such as Banco Santander, and Banco Central-Hispano. He is a published author of currency trading books.